Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-26,586
Closed -$212K 2042
2023
Q3
$212K Buy
26,586
+9,521
+56% +$110K ﹤0.01% 1584
2023
Q2
$222K Buy
+17,065
New +$209K ﹤0.01% 1577
2022
Q4
Sell
-2,562
Closed -$44K 1946
2022
Q3
$44K Buy
+2,562
New +$47.2K ﹤0.01% 1688
2022
Q1
Sell
-1,688
Closed -$49K 1688
2021
Q4
$49K Buy
+1,688
New +$61.7K ﹤0.01% 1610

Other funds holding LUNG

Amundi's LUNG Position: Q4 2023 in Review

Amundi sold out of Pulmonx (LUNG) in Q4 2023, closing a stake of 26,586 shares — an estimated $212K sold.

Amundi first reported a position in LUNG in Q4 2021 and held it in 4 quarters. The position peaked at $222K in Q2 2023. 123 funds tracked by Wall St. Rank hold LUNG as of Q4 2023.

  • Amundi reported no remaining Pulmonx position as of Q4 2023 after selling out during the quarter.
  • Amundi sold 26,586 Pulmonx shares in Q4 2023, an estimated $212K.
  • Amundi first reported a position in Pulmonx in Q4 2021 and held it in 4 quarters.
  • Amundi's Pulmonx position peaked at $222K in Q2 2023.
  • 123 funds tracked by Wall St. Rank held Pulmonx as of Q4 2023.

Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.